Evidence map›Paper›PMID 26212363›Full record

ArticleArchives of virology2015

Complete genome sequence of trivittatus virus.

Allison Groseth, Veronica Vine, Carla Weisend, Hideki Ebihara

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Archives of virology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Allison GrosethLaboratory of Virology, Molecular Virology and Host-Pathogen Interactions Unit, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, 903 South 4th Street, Hamilton, MT, 59840, USA.
Veronica VineLaboratory of Virology, Molecular Virology and Host-Pathogen Interactions Unit, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, 903 South 4th Street, Hamilton, MT, 59840, USA.
Carla WeisendLaboratory of Virology, Molecular Virology and Host-Pathogen Interactions Unit, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, 903 South 4th Street, Hamilton, MT, 59840, USA.
Hideki EbiharaLaboratory of Virology, Molecular Virology and Host-Pathogen Interactions Unit, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Rocky Mountain Laboratories, 903 South 4th Street, Hamilton, MT, 59840, USA. ebiharah@niaid.nih.gov.
Rocky Mountain Institute · USNational Institute of Allergy and Infectious Diseases · US

Funding

Molecular Determinants of Human Pathogenic Bunyavirus Virulence and EvolutionZIAAI001137 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI EBIHARA, HIDEKI · 2011 to 2016
$3.3M
Intramural NIH HHS ZIA AI001137
6 · The paper itself

Abstract

Trivittatus virus (family Bunyaviridae, genus Orthobunyavirus) represents an important genetic intermediate between the California encephalitis group and the Bwamba/Pongola and Nyando groups. Here, we report the first complete genome sequence of the prototype (Eklund) strain, isolated in 1948, which, interestingly, shows only a few differences when compared to partial sequences of modern strains.

Indexed as

Genome, ViralAedesAnimalsBase SequenceMolecular Sequence DataOpen Reading FramesOrthobunyavirusPhylogeny

Identifiers

PMID26212363
PMCPMC4591928
OpenAlexW1564656905

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.